BACKGROUND: Although depression is a highly prevalent condition that occurs in all ethnic groups, the influence of ethnicity on treatment response still remains unclear. METHODS: A prospective 8-week, open-label clinical trial comparing the efficacy and side effects of citalopram (CIT) with dose escalation (20-60 mg/day) was performed in African-Americans and Caucasians with nonpsychotic major depression. The intent-to-treat sample consisted of 301 participants (169 African-Americans and 132 Caucasians). RESULTS: Although African-Americans were more socially disadvantaged and had a more severe depression, outcomes between the groups were similar. Remission rates were approximately 50% in both groups and about 2/3 of participants met response criteria. Retention was greater than 75% in both groups, with no differences in dropout rate. There were no differences in the number of completers, number of visits made, final dose of CIT, or in side effect profiles. CONCLUSIONS: These results confirm the growing body of evidence, including recent studies using measurement-based care, that patients from minority groups have outcomes that are similar to those of Caucasians. The provision of measurement-based care and encouragement of patient participation can reduce ethnic differences in response to treatment for depression.
BACKGROUND: Although depression is a highly prevalent condition that occurs in all ethnic groups, the influence of ethnicity on treatment response still remains unclear. METHODS: A prospective 8-week, open-label clinical trial comparing the efficacy and side effects of citalopram (CIT) with dose escalation (20-60 mg/day) was performed in African-Americans and Caucasians with nonpsychotic major depression. The intent-to-treat sample consisted of 301 participants (169 African-Americans and 132 Caucasians). RESULTS: Although African-Americans were more socially disadvantaged and had a more severe depression, outcomes between the groups were similar. Remission rates were approximately 50% in both groups and about 2/3 of participants met response criteria. Retention was greater than 75% in both groups, with no differences in dropout rate. There were no differences in the number of completers, number of visits made, final dose of CIT, or in side effect profiles. CONCLUSIONS: These results confirm the growing body of evidence, including recent studies using measurement-based care, that patients from minority groups have outcomes that are similar to those of Caucasians. The provision of measurement-based care and encouragement of patient participation can reduce ethnic differences in response to treatment for depression.
Authors: Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava Journal: Am J Psychiatry Date: 2006-01 Impact factor: 18.112
Authors: Patricia A Areán; Liat Ayalon; Enid Hunkeler; Elizabeth H B Lin; Lingqi Tang; Linda Harpole; Hugh Hendrie; John W Williams; Jürgen Unützer Journal: Med Care Date: 2005-04 Impact factor: 2.983
Authors: Rahn K Bailey; Craig H Mallinckrodt; Madelaine M Wohlreich; John G Watkin; John M Plewes Journal: J Natl Med Assoc Date: 2006-03 Impact factor: 1.798
Authors: Charles A Hall; Kevin M Simon; Eric J Lenze; Mary Amanda Dew; Amy Begley; Meryl A Butters; Daniel M Blumberger; Jacqueline A Stack; Benoit Mulsant; Charles F Reynolds Journal: Psychiatr Serv Date: 2015-08-17 Impact factor: 3.084
Authors: Jonathan R Schettino; Natasha T Olmos; Hector F Myers; Nataria T Joseph; Russell E Poland; Ira M Lesser Journal: Ment Health Relig Cult Date: 2011-06-13
Authors: Nataria T Joseph; Hector F Myers; Jonathan R Schettino; Natasha T Olmos; Consuelo Bingham-Mira; Ira M Lesser; Russell E Poland Journal: Psychiatry Date: 2011 Impact factor: 2.458
Authors: Stephen E Gilman; Garrett M Fitzmaurice; Martha L Bruce; Thomas Ten Have; M Maria Glymour; Hannah Carliner; George S Alexopoulos; Benoit H Mulsant; Charles F Reynolds; Alex Cohen Journal: Epidemiology Date: 2013-01 Impact factor: 4.822
Authors: John Kasckow; Erin Ingram; Charlotte Brown; James D Tew; Kyaien O Conner; Jennifer Q Morse; Gretchen L Haas; Charles F Reynolds; David W Oslin Journal: Psychiatr Serv Date: 2011-04 Impact factor: 3.084
Authors: Russell E Poland; Lev Gertsik; Joya T Favreau; Shawnee I Smith; James M Mirocha; Uma Rao; Eric S Daar Journal: J Altern Complement Med Date: 2012-10-25 Impact factor: 2.579
Authors: Russell E Poland; Ira M Lesser; Yu-Jui Yvonne Wan; Lev Gertsik; Jie Yao; Leslie J Raffel; Keh-Ming Lin; Hector F Myers Journal: Life Sci Date: 2013-04-03 Impact factor: 5.037